About US
Contact us
-
Simplified Delivery Solution To Speed Clinical Proof Of ConceptTo help drug development scientists reach their "first dose in man" faster, Catalent Pharma Solutions, LLC has added the Xcelodose micro-dosing system to its Research Triangle Park (RTP), North Caro2010/11/9
-
Selection of new members for the Tenth Chinese Pharmacopoeia Commission startedSelection of new members for the Tenth Chinese Pharmacopoeia Commission started The 2010 edition of Chinese Pharmacopoeia has come into effect as of October 1, 2010. The selection of new members f2010/11/8
-
BASF AND MONSANTO ANNOUNCE PROGRESS IN DICAMBA FORMULATIONSBASF AND MONSANTO ANNOUNCE PROGRESS IN DICAMBA FORMULATIONS For immediate release Media Inquiries: Janice Person, Monsanto Company - +1.901.320.5760 Global queries: Elise Kissling, BASF SE - +42010/11/8
-
SFDA issues The Third National Drug Quality Announcement of 2010SFDA issues The Third National Drug Quality Announcement of 2010 To intensify drug supervision and ensure drug safety for the public, the State Food and Drug Administration (SFDA) organized nation2010/11/5
-
SFDA releases the third issue of 2010 National Medical Device Quality AnnouncementSFDA releases the third issue of 2010 National Medical Device Quality Announcement The State Food and Drug Administration (SFDA) released the third issue of 2010 National Medical Device Quality A2010/11/5
-
ADVENTRX submits NDA for Exelbine to FDAADVENTRX submits NDA for Exelbine to FDA ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration2010/11/4
-
OMJPI enters agreement with Watson to distribute generic version of CONCERTA tabletsOMJPI enters agreement with Watson to distribute generic version of CONCERTA tablets Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) today announced it has entered into a supply and distributio2010/11/4
-
GSK receives Japanese approval for Revolade for treatment of chronic ITPGSK receives Japanese approval for Revolade for treatment of chronic ITP Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced its partner GlaxoSmithKline (NYSE:GSK) was granted approv2010/11/3
-
FDA announces partnership agreement with University of Rochester to form ACTION InitiativeFDA announces partnership agreement with University of Rochester to form ACTION Initiative The U.S. Food and Drug Administration today announced a partnership agreement with the University of Roch2010/11/3
-
Significant Capacity Expansion for Evonik Industries' Precipitated SilicasSignificant Capacity Expansion for Evonik Industries' Precipitated Silicas ·Production capacity to grow 25 percent over next few years ·Focus on Asia and Europe New products to be launched on2010/11/2